I. Situation of the Board Meeting
Sunflower Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") held the 19th meeting of the 5th Board of Directors from March 31, 2026, to April 9, 2026, via communication means. The meeting was convened by the chairman and the notice of the meeting was sent on March 27, 2026, through email.
The meeting was attended by nine directors, with all nine participating in the meeting. The meeting followed the procedures outlined in the Company Law and relevant regulations.
II. Situation of the Board Meeting Resolutions
- Approval of the Proposal on Establishing a Subsidiary
The Company will use its own funds of 1,000,000 RMB to establish a subsidiary named Sunflower Group (Hubei) Pharmaceutical Co., Ltd., which will manage the investment in the subsidiary.
The above information has been disclosed through designated information disclosure media, including the Securities Times and China Securities Journal, and the website of Cninfo (http://www.cninfo.com.cn).
The result of the vote: 9 votes in favor, 0 votes against, 0 abstentions, passed.
- Approval of the Proposal on External Donations
To fulfill social responsibilities, the Company will assist in public welfare activities and effectively implement "production and operation, social contribution, and return to shareholders." The Company will allocate no more than 3,000,000 RMB for donations and will manage the situation through the relevant departments.